摘要
目的探讨乌司他丁联合奥曲肽治疗重症急性胰腺炎的临床效果。方法根据研究需要选取2014年1月至2015年1月于本院住院治疗的重症急性胰腺炎病例66例作为研究对象，分为对照组和治疗组，各33例。对照组奥曲肽治疗，治疗组在此基础上加用乌司他丁治疗。对比两组临床疗效。结果治疗组有效率、血淀粉酶恢复时间、尿淀粉酶恢复时间显著优于对照组，差异有统计学意义（P〈0．01）。结论乌司他丁联合奥曲肽在急性胰腺炎的治疗方面具有良好疗效，值得推荐。
Objective To study the clinical effect of ulinastatin combined with octreotide for severe acute pancreatitis （SAP）. Method 66 patients with SAP treated at our hospital from January, 2014 to January, 2015 were selected and were randomly divided into a control group and an observation group, 33 cases for each group. The control group were treated with octreotide; and in addition, the observation group were treated with ulinastatin. The clinical effects were compared between these two groups. Results The overall effective rate was significantly lower in the control group than in the observation group （78.9% vs. 97.0%, P〈0.05）; the recovery times of blood amylase and urine amylase were significantly shorter in the observation group than in the control group （P〈0.05）. Conclusions Ulinastatin combined with octreotide for SAP is effective and worth being recommended in clinical practice.
出处
《国际医药卫生导报》
2016年第10期1439-1441,共3页
International Medicine and Health Guidance News
